AzTrials
AzTrials

Cardiometabolic Risk FactorsNCT06358859

Delta GREENS Food is Medicine Intervention

A study testing Food is Medicine in people with Cardiometabolic Risk Factors and Diabetes, run by Tufts University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
What is being tested?
Food is Medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
5 Jun 2024to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patient at participating Delta Health Center (DHC) clinics
  • BMI: ≥ 25
  • Hemoglobin A1C (HbA1c): >5.7 to 8.5%, inclusive

Who cannot join

  • Type 1 diabetes
  • Current use of incretin agonists (e.g., semaglutide, dulaglutide, liraglutide)
  • Uncontrolled hypertension:
  • Systolic blood pressure > 160 mmHg
  • Diastolic blood pressure > 100 mmHg
  • Severe symptomatic cardiovascular disease
Show all 20Show fewer
  • Recent (6 months) history of:
  • Myocardial infarction
  • Percutaneous coronary intervention
  • Coronary artery bypass graft
  • Cerebrovascular disease
  • Participant in diabetes, nutrition, or weight intervention research in the last 12 months
  • Another family member or household member is a study participant
  • History of bariatric surgery or considering bariatric surgery in the next year or prior bariatric surgery
  • Lack of safe, stable residence and ability to store produce
  • Lack of telephone
  • Pregnancy/breastfeeding or intended pregnancy in the next year
  • Drug or alcohol misuse that would impair the ability to complete study activities
  • Known psychosis or major psychiatric illness that prevents participation in study activities
  • Any other reason that in the investigators' best judgment places the participants at risk or increases likelihood of poor adherence

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Tufts University

    Boston, Massachusetts, 02111

Other trials in United States

About this study

Official title: Delta GREENS Mississippi Food is Medicine Intervention

Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and ~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta GREENS Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Read the detailed description

Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. In fact, about 77% of Mississippi counties meet the U.S. Department of Agriculture's definition of food deserts. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and ~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Food is medicine programs -- health clinic mobile markets, produce prescription programs, and produce delivery - hold significant promise for addressing the alarming crisis of nutrition-related diseases. Across the U.S., Food is Medicine programs are in their infancy and accelerating at a rapid pace; since 2019, USDA has funded 116 produce prescription grants. However, no studies have evaluated the impact of food is medicine programs in a rigorous, randomized controlled trial measuring objective cardiometabolic risk factors among minority populations in communities with persistent disadvantage. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. This study is focused on Delta GREENS Food is Medicine (FIM) Project. Delta GREENS Food is Medicine is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. Participants will be patients at Delta Health Center (DHC) clinics in Mississippi. The project capitalizes on the past success of community-based efforts and decades of community-engaged research at Tufts University, including prior nutrition work in the Delta region. Despite its unique cultural and agricultural background, the Mississippi Delta has experienced persistent health challenges intertwined with poverty. By collaborating and building upon previous successes, the Delta GREENS FIM Project aims to address these challenges, and become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Being tested
Food is Medicine
Keywords
Food is Medicine, Diabetes, High blood pressure, Cardiometabolic risk factors, Nutrition-related diseases
Medical subject headings
Diabetes Mellitus, Hypertension, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Food is MedicineOther

    Regularly distributed fruit and vegetable produce boxes and nutrition education materials.

Study groups in NCT06358859
Study groupRoleWhat they receive
InterventionExperimentalThe intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group.
Receives: Other: Food is Medicine
ControlNo interventionThe control group will receive produce boxes later, after they complete study activities.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in hemoglobin A1c (HbA1c)

    Change in HbA1c in the intervention group compared to the control group

    Measured: 12 month study period for each participant

Secondary outcomes (9)
  1. Change in cardiometabolic risk factor composite score

    Change in cardiometabolic risk factor composite score which is computed using LDL and non-HDL cholesterol, blood pressure and HbA1c measures), in the intervention group compared to the control group.

    Measured: 12 month study period for each participant

  2. Change in BMI

    Change in body mass index (BMI) in intervention group compared to control group

    Measured: 12 month study period for each participant

  3. Change in LDL cholesterol

    Change in LDL cholesterol levels in intervention group compared to the control group

    Measured: 12 month study period for each participant

  4. Change in non-HDL cholesterol

    Change in non-HDL cholesterol levels in intervention group compared to the control group

    Measured: 12 month study period for each participant

  5. Change in blood pressure

    Change in blood pressure in intervention group compared to the control group

    Measured: 12 month study period for each participant

  6. Change in nutrition security, assessed via a survey

    Change in nutrition security in intervention group compared to the control group. This outcome measure will be assessed via a survey.

    Measured: 12 month study period for each participant

  7. Change in dietary intake of fruits and vegetables, assessed via a survey

    Change in dietary intake of fruits and vegetables in intervention group compared to the control group. This outcome measure will be assessed via a survey.

    Measured: 12 month study period for each participant

  8. Change in health care utilization, assessed via review of Electronic Health Records (EHR)

    Change in health care utilization, including instances of hospitalization and emergency room visit, in intervention group compared to the control group. This outcome measure will be assessed via review of Electronic Health Records (EHR).

    Measured: 12 month study period for each participant

  9. Change in food insecurity, assessed via a survey

    Change in food insecurity in the intervention group compared to the control group. This outcome measure will be assessed via a survey.

    Measured: 12 month study period for each participant

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2024
  2. Study start5 Jun 2024
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The primary objective is to test whether a multi-level, community-engaged intervention with a food-is-medicine program in the Mississippi Delta can improve metabolic disease in specific minority groups. The basic study design is a cluster randomized controlled trial (RCT), with equal numbers of participants randomized to intervention and control groups. Each participant will be enrolled in the study for 12 months. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group during their 12-month study period. The control group will receive produce boxes later, after their 12-month study participation has ended. Participants will be patients at participating Delta Health Center (DHC) clinics in Mississippi.
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06358859
Sponsor's protocol ID
STUDY00004203
Other IDs
1R01MD018208-01
Status last verified
Aug 2026
First submitted
4 Apr 2024
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Food is Medicine in people with Cardiometabolic Risk Factors and Diabetes, run by Tufts University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in hemoglobin A1c (HbA1c) (time frame: 12 month study period for each participant). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in